Skip to content
LTGOLatigo Biotherapeutics, Inc.

Earnings

When Latigo Biotherapeutics, Inc. reports, what it reported each quarter, and how the stock took the results.

6 quarters. Mar 31, 2025 to Sep 30, 2026. mixed units.

Quarter by quarter

Q3 2026-$20.95MNo Q3 2025 on file

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 5, 2026 · pre-marketNov 5, 202636 d10-Q——-$0.557.0%
Q2 2026Jun 30, 2026Sep 3, 2026 · after-hoursSep 3, 202665 d10-Q——-$27.59+1.9%
Q1 2026Mar 31, 2026————————
FY 2025
Q3 2025Sep 30, 2025——————-$29.50—
Q2 2025Jun 30, 2025——————-$36.52—
Q1 2025Mar 31, 2025————————

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 5, 2026448582
10-QSep 3, 2026381969

Provenance

ProvenanceData status and checks

Latigo Biotherapeutics, Inc. · CIK 2056611 · Engraved from SEC EDGAR